Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer

Obstetrics and Gynecology

Volumn 124, Issue 6, 2014, Pages 1098-1104

  Frumovitz, Michael ^a   Jhingran, Anuja ^a   Soliman, Pamela T ^a   Klopp, Ann H ^a   Schmeler, Kathleen M ^a   Eifel, Patricia J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMORBIDITY; ETHNICITY; FEMALE; HISTOLOGY; HUMAN; HYDRONEPHROSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MORBID OBESITY; MORTALITY; MULTIMODALITY CANCER THERAPY; NATIONAL HEALTH ORGANIZATION; OVERALL SURVIVAL; RACE; RETROSPECTIVE STUDY; RISK FACTOR; SELF REPORT; SMOKING; SOCIAL STATUS; TUMOR VOLUME; UNDERWEIGHT; UTERINE CERVIX CANCER; VERY ELDERLY; CARCINOMA; COMPLICATION; EPIDEMIOLOGY; MIDDLE AGED; UNITED STATES; UTERINE CERVIX TUMOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; HUMANS; MIDDLE AGED; OBESITY, MORBID; RETROSPECTIVE STUDIES; RISK FACTORS; TEXAS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84916936257     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000558     Document Type: Article

References (24)

1. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-91.
2. Wee CC, McCarthy EP, Davis RB, Phillips RS. Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care? Ann Intern Med 2000;132:697-704.
3. Akers AY, Newmann SJ, Smith JS. Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Curr Probl Cancer 2007;31:157-81.
4. Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, et al. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006;95(suppl 1):S43-103.
5. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40: 373-83.
6. Eifel PJ, Jhingran A, Levenback CF, Tucker S. Predictive value of a proposed subclassification of stages I and II cervical cancer based on clinical tumor diameter. Int J Gynecol Cancer 2009; 19:2-7.
7. Eifel PJ. The uterine cervix. In: Cox JD, Ang KK, editors. Radiation oncology: rationale, technique, results. St Louis (MO): Mosby; 2003. p. 681-723.
8. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for highrisk cervical cancer. N Engl J Med 1999;340:1137-43.
9. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38.
10. Lew EA, Garfinkel L. Variations in mortality by weight among 750, 000 men and women. J Chronic Dis 1979;32:563-76.
11. Freedland SJ, Platz EA. Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev 2007; 29:88-97.
12. Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 2005;23:1370-8.
13. Dignam JJ, Polite BN, Yothers G, Raich P, Colangelo L, O'Connell MJ, et al. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 2006;98:1647-54.
14. Frumovitz M, Sun CC, Jhingran A, Schmeler KM, Dos Reis R, Milam MR, et al. Radical hysterectomy in obese and morbidly obese women with cervical cancer. Obstet Gynecol 2008;112: 899-905.
15. Fisher C, Fortenberry C, Jhingran A, Eifel P. Novel technique for simulation and external beam treatment planning for obese patients. Pract Radiat Oncol 2011;1:152-5.
16. Sweigart KD. A simple method of alignment for pelvic irradiation in obese patients. Med Dosim 2002;27:269-70.
17. Wong JR, Gao Z, Merrick S, Wilson P, Uematsu M, Woo K, et al. Potential for higher treatment failure in obese patients: correlation of elevated body mass index and increased daily prostate deviations from the radiation beam isocenters in an analysis of 1, 465 computed tomographic images. Int J Radiat Oncol Biol Phys 2009;75:49-55.
18. Millender LE, Aubin M, Pouliot J, Shinohara K, Roach M III. Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004;59:6-10.
19. Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, et al. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2012;30: 1553-61.
20. Monk BJ, Tewari KS, Koh WJ. Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol 2007;25:2952-65.
21. Rosner GL, Hargis JB, Hollis DR, Budman DR, Weiss RB, Henderson IC, et al. Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541. J Clin Oncol 1996;14:3000-8.
22. Pollak M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer 2012;12: 159-69.
23. Shen MR, Hsu YM, Hsu KF, Chen YF, Tang MJ, Chou CY. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling. Carcinogenesis 2006;27: 962-71.
24. Huang YF, Shen MR, Hsu KF, Cheng YM, Chou CY. Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer. Br J Cancer 2008;99:1096-102.